WHO

Customers

Our potential customers are teenagers and young adults. According to the previous study by Gibson et al. (2023), people who are most likely to develop anxiety disorder due to minor scars were from the age group of 15 to 40, a result shown by the multivariate logistic regression model (Figure 2). 

​

​

​

​

​

​

​

​

​

​

​

​

​

Figure 2. The risk of developing anxiety disorder as a result of scarring. The multivariate logistic regression model used multiple variables, including gender, incident types, etc., to predict the probability of anxiety. (Gibson et al., 2023). 

Likewise, as shown in Figure 3, people who are most likely to get depression after being scarred were also aged from 15 to 40 (Gibson et al., 2023). This finding confirms the potential customer populations of our product.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Figure 3. The risk of developing depression as a result of scarring. The peaks occurred in the age group of 15 to 40 (Gibson et al., 2023).  

Sponsors

Our potential sponsors form three categories: 1. consumable suppliers; 2. equipment providers; 3. clients.
 

1. Consumable suppliers:
   We aim to apply for sponsorship from the following companies, including but not limited to:
   - Sigma-Aldrich
   - Avantor
    

2. Equipment providers:
   We aim to apply for sponsorship from the following companies, including but not limited to:
   - Thermo Fisher Scientific
   - Invitrogen
    

3. Clients:
   We may also have some potential clients who are interested in sponsoring us, which may include:
   - St Mary's Hospital
   - Hammersmith Hospital
   - Charing Cross Hospital

​

We will also apply for bursaries and studentships at Imperial and Royal Societies to fund our project.​

References

Gibson, J. A. G., Dobbs, T. D., Griffiths, R., Song, J., Akbari, A., Bodger, O., Hutchings, H. A., Lyons, R. A., John, A. & Whitaker, I. S. (2023) The association of anxiety disorders and depression with facial scarring: population-based, data linkage, matched cohort analysis of 358 158 patients. BJPsych Open. 9 (6), e212. doi: 10.1192/bjo.2023.547.